Synopsis
Distinguish benign pleural markers, asbestosis and asbestos-related malignancy, take a defensible exposure history and route suspicious symptoms urgently without overstating screening benefits.
- Asbestos exposure can cause pleural plaques, benign pleural effusion, diffuse pleural thickening, rounded atelectasis, asbestosis, lung cancer and malignant mesothelioma.
- Disease typically follows a long latency, so relevant work may have occurred decades before retirement, migration or symptom onset.
- Pleural plaques are markers of previous exposure and are usually asymptomatic; they are not themselves malignant or a precursor that transforms into mesothelioma.
- Asbestosis is diffuse pulmonary fibrosis caused by substantial cumulative asbestos exposure and must be differentiated from IPF and other fibrotic ILDs.
- Mesothelioma commonly presents with progressive unilateral chest pain, breathlessness, pleural effusion or pleural thickening and nodularity.
- A normal chest radiograph cannot rule out early pleural malignancy in a symptomatic person, and previous normal imaging does not provide lasting reassurance.
- Smoking and asbestos exposure together greatly increase lung-cancer risk; stopping smoking is a valuable intervention even long after occupational exposure ended.
- Do not use a plaque burden to calculate an individual's mesothelioma future or promise that routine CT surveillance will prevent asbestos-related cancer.
- Document employers, dates, trades, tasks, materials, co-workers, lagging or insulation work and respiratory protection rather than recording only 'builder'.
- Discuss Industrial Injuries Disablement Benefit, relevant lump-sum schemes and independent legal or welfare advice without making eligibility promises outside the responsible service.
Key red flags
Unilateral progressive chest pain, breathlessness, recurrent exudative effusion, nodular pleural thickening or loss of hemithoracic volume warrants urgent cancer-pathway referral.
Haemoptysis, unexplained weight loss, persistent cough, focal mass, lobar collapse, supraclavicular node or clubbing requires the current suspected-lung-cancer pathway whether or not asbestosis is present.
A large effusion causing hypoxaemia, severe dyspnoea or mediastinal compromise needs same-day pleural assessment and symptom relief with appropriately planned diagnostic sampling.
Investigation priorities
Establish plausible exposure, latency and potential ongoing risk.
Management branches
A patient reports asbestos contact or incidental plaques are found.
- Take a task-based lifetime exposure and smoking history, assess respiratory symptoms and explain that plaques confirm exposure but do not themselves become cancer.
- For asymptomatic plaques, avoid attributing unrelated breathlessness or arranging unsupported serial CT; address smoking cessation and provide symptom safety-netting.
- When breathlessness or physiological abnormality exists, investigate COPD, cardiac disease, diffuse pleural thickening, asbestosis and other ILD rather than assuming plaques are causal.
- Discuss occupational documentation and signpost benefits or independent legal advice where appropriate, clearly separating clinical opinion from eligibility decisions.